Correlation Between Mineralys Therapeutics, and Inovio Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Inovio Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Inovio Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Inovio Pharmaceuticals, you can compare the effects of market volatilities on Mineralys Therapeutics, and Inovio Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Inovio Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Inovio Pharmaceuticals.
Diversification Opportunities for Mineralys Therapeutics, and Inovio Pharmaceuticals
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mineralys and Inovio is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Inovio Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inovio Pharmaceuticals and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Inovio Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inovio Pharmaceuticals has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Inovio Pharmaceuticals go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Inovio Pharmaceuticals
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 0.73 times more return on investment than Inovio Pharmaceuticals. However, Mineralys Therapeutics, Common is 1.36 times less risky than Inovio Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Inovio Pharmaceuticals is currently generating about -0.03 per unit of risk. If you would invest 1,600 in Mineralys Therapeutics, Common on August 30, 2024 and sell it today you would lose (289.00) from holding Mineralys Therapeutics, Common or give up 18.06% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 91.72% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Inovio Pharmaceuticals
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Inovio Pharmaceuticals |
Mineralys Therapeutics, and Inovio Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Inovio Pharmaceuticals
The main advantage of trading using opposite Mineralys Therapeutics, and Inovio Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Inovio Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inovio Pharmaceuticals will offset losses from the drop in Inovio Pharmaceuticals' long position.| Mineralys Therapeutics, vs. Ultra Clean Holdings | Mineralys Therapeutics, vs. Playtika Holding Corp | Mineralys Therapeutics, vs. Helmerich and Payne | Mineralys Therapeutics, vs. Capital Clean Energy |
| Inovio Pharmaceuticals vs. Novavax | Inovio Pharmaceuticals vs. Vaxart Inc | Inovio Pharmaceuticals vs. Enveric Biosciences | Inovio Pharmaceuticals vs. Ocean Biomedical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |